205 related articles for article (PubMed ID: 21513515)
1. Pulmonary arterial dysfunction in insulin resistant obese Zucker rats.
Moral-Sanz J; Menendez C; Moreno L; Moreno E; Cogolludo A; Perez-Vizcaino F
Respir Res; 2011 Apr; 12(1):51. PubMed ID: 21513515
[TBL] [Abstract][Full Text] [Related]
2. Decreased Kv1.5 expression in intrauterine growth retardation rats with exaggerated pulmonary hypertension.
Lv Y; Tang LL; Wei JK; Xu XF; Gu W; Fu LC; Zhang LY; Du LZ
Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(11):L856-65. PubMed ID: 24077947
[TBL] [Abstract][Full Text] [Related]
3. Elevated pulmonary arterial pressure in Zucker diabetic fatty rats.
Morales-Cano D; Callejo M; Barreira B; Mondejar-Parreño G; Esquivel-Ruiz S; Ramos S; Martín MÁ; Cogolludo A; Moreno L; Perez-Vizcaino F
PLoS One; 2019; 14(1):e0211281. PubMed ID: 30689673
[TBL] [Abstract][Full Text] [Related]
4. Enhanced AT1 receptor-mediated vasocontractile response to ANG II in endothelium-denuded aorta of obese Zucker rats.
Siddiqui AH; Hussain T
Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1722-7. PubMed ID: 17142345
[TBL] [Abstract][Full Text] [Related]
5. Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertension.
Billaud M; Dahan D; Marthan R; Savineau JP; Guibert C
Respir Res; 2011 Mar; 12(1):30. PubMed ID: 21414209
[TBL] [Abstract][Full Text] [Related]
6. Selective resistance to vasoactive effects of insulin in muscle resistance arteries of obese Zucker (fa/fa) rats.
Eringa EC; Stehouwer CD; Roos MH; Westerhof N; Sipkema P
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1134-9. PubMed ID: 17623751
[TBL] [Abstract][Full Text] [Related]
7. A novel inhibitor of inducible nitric oxide synthase, ONO-1714, does not ameliorate hypoxia-induced pulmonary hypertension in rats.
Jiang BH; Maruyama J; Yokochi A; Mitani Y; Maruyama K
Lung; 2007; 185(5):303-308. PubMed ID: 17721804
[TBL] [Abstract][Full Text] [Related]
8. miR-1 is increased in pulmonary hypertension and downregulates Kv1.5 channels in rat pulmonary arteries.
Mondejar-Parreño G; Callejo M; Barreira B; Morales-Cano D; Esquivel-Ruiz S; Moreno L; Cogolludo A; Perez-Vizcaino F
J Physiol; 2019 Feb; 597(4):1185-1197. PubMed ID: 29717493
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.
Paffett ML; Lucas SN; Campen MJ
Vascul Pharmacol; 2012; 56(1-2):64-73. PubMed ID: 22146233
[TBL] [Abstract][Full Text] [Related]
10. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of chronic hypoxia and intermittent hypocapnic and eucapnic hypoxia on pulmonary vasoreactivity.
Snow JB; Kitzis V; Norton CE; Torres SN; Johnson KD; Kanagy NL; Walker BR; Resta TC
J Appl Physiol (1985); 2008 Jan; 104(1):110-8. PubMed ID: 17947499
[TBL] [Abstract][Full Text] [Related]
12. [Effects of recombinant human morphogenetic protein-2 on pulmonary artery pressure in acute lung injury caused by endotoxin and mechanism thereof: experiment with rats].
Shan SM; Pei L; Wang JK
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3201-6. PubMed ID: 17313787
[TBL] [Abstract][Full Text] [Related]
13. Role for PKCβ in enhanced endothelin-1-induced pulmonary vasoconstrictor reactivity following intermittent hypoxia.
Snow JB; Gonzalez Bosc LV; Kanagy NL; Walker BR; Resta TC
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L745-54. PubMed ID: 21803871
[TBL] [Abstract][Full Text] [Related]
14. Vascular wall dysfunction in JCR:LA-cp rats: effects of age and insulin resistance.
O'brien SF; Russell JC; Davidge ST
Am J Physiol; 1999 Nov; 277(5):C987-93. PubMed ID: 10564092
[TBL] [Abstract][Full Text] [Related]
15. Impaired mitochondria-dependent vasodilation in cerebral arteries of Zucker obese rats with insulin resistance.
Katakam PV; Domoki F; Snipes JA; Busija AR; Jarajapu YP; Busija DW
Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R289-98. PubMed ID: 19005015
[TBL] [Abstract][Full Text] [Related]
16. Beraprost Upregulates KV Channel Expression and Function via EP4 Receptor in Pulmonary Artery Smooth Muscle Cells Obtained from Rats with Hypoxia-Induced Pulmonary Hypertension.
Tian H; Fan F; Geng J; Deng J; Tian H
J Vasc Res; 2019; 56(4):204-214. PubMed ID: 31189158
[TBL] [Abstract][Full Text] [Related]
17. In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats.
Pozeg ZI; Michelakis ED; McMurtry MS; Thébaud B; Wu XC; Dyck JR; Hashimoto K; Wang S; Moudgil R; Harry G; Sultanian R; Koshal A; Archer SL
Circulation; 2003 Apr; 107(15):2037-44. PubMed ID: 12695303
[TBL] [Abstract][Full Text] [Related]
18. Increased Expression of MicroRNA-206 Inhibits Potassium Voltage-Gated Channel Subfamily A Member 5 in Pulmonary Arterial Smooth Muscle Cells and Is Related to Exaggerated Pulmonary Artery Hypertension Following Intrauterine Growth Retardation in Rats.
Lv Y; Fu L; Zhang Z; Gu W; Luo X; Zhong Y; Xu S; Wang Y; Yan L; Li M; Du L
J Am Heart Assoc; 2019 Jan; 8(2):e010456. PubMed ID: 30636484
[TBL] [Abstract][Full Text] [Related]
19. Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
Yasuda T; Tada Y; Tanabe N; Tatsumi K; West J
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L667-74. PubMed ID: 21856816
[TBL] [Abstract][Full Text] [Related]
20. Effects of streptozotocin-induced diabetes on the pharmacology of rat conduit and resistance intrapulmonary arteries.
Gurney AM; Howarth FC
Cardiovasc Diabetol; 2009 Jan; 8():4. PubMed ID: 19159454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
